Skip Navigation Links.

Transgene Biotek Ltd


BSE: 526139 | NSE: NA | ISIN: INE773D01018 
Market Cap: [Rs.Cr.] 12 | Face Value: [Rs.] 10
Industry: Healthcare

 Discuss this stock

Board Meet

30-May-13 
Audited Results 
15-Feb-13 
Quarterly Results 
15-Nov-12 
Quarterly Results 
03-Sep-12 
Transgene Biotek Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on September 03, 2012: 1. To approve the Directors's Report for the year ended March 31, 2012. 2. To fix the date for convening the 22nd Annual General Meeting of the Company. 3. To fix the date of book closure. 4. To consider the proposal for delisting the equity Shares of the Company from all the recognized Indian stock exchanges. Transgene Biotek Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 03, 2012, inter alia, has decided to delist the equity shares of the Company from the all the recognized Indian Stock Exchanges subject to the approval of the Shareholders of the company and statutory approvals as are applicable in this regard. (As per BSE Announcement Dated on 04.09.2012)  
15-Aug-12 
Quarterly Results 

AGM

29-Sep-12
AGM 29.09.2012 Transgene Biotek Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company was held on September 29, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com). (As Per BSE Announcement Dated on 01.10.2012) 
30-Sep-11
AGM 30/09/2011 Transgene Biotek Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on September 30, 2011, inter alia, have passed the following resolutions: - Ordinary Business: 1. Adoption of audited Annual accounts for the year ended March 31, 2011 alongwith the reports of Directors and Auditors thereon. 2. Re-appointment of Sri. S. S. Marthi as director of the Company. 3. Re-appointment of Dr. P. K. Ghosh as director of the Company. 4. Appointment of M/s. Sarath & Associates Statutory Auditors of the Company. - Special Business: 5. Re-appointment of Dr. K. K. Rao as Managing Director of the Company - Ordinary Resolution. 6. Increase in limits of investments in the Company by FIIs, etc - Special Resolution. (As Per BSE Announcement Website dated on 03.10.2011) 
30-Sep-10
AGM 30/09/2010 
30-Sep-09
AGM 30/09/2009 
29-Nov-08
AGM 29/11/2008 

EGM

18-Apr-11
Transgene Biotek Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on April 18, 2011, for obtaining the fresh consent for the allotment of 7,50,000 Equity shares of Rs. 10/- each allotted to Dr. K. Koteswara Rao, Promoter of the Company, @ Rs. 80/- per share pursuant to the consent given by the shareholders of the Company at the Extra-ordinary General Meeting held on June 18, 2008 against the interest free unsecured loans brought in by him and his family. Transgene Biotek Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on April 18, 2011, have given their fresh consent for the allotment of 7,50,000 Equity shares of Rs. 10/- each allotted to Dr. K. Koteswara Rao, Promoter of the company, @ Rs. 80/- per share pursuant to the consent given by the shareholders of the Company at the Extra-ordinary General Meeting held on June 18, 2008 against the interest free unsecured loans brought in by him and his family. (As Per BSE Announcement Dated on 25.04.2011) 
01-Nov-10
Transgene Biotek Ltd has informed BSE that the members at the Extra-ordinary General Meeting (EGM) of the Company held on November 01, 2010, have approved as special resolutions unanimously : 1. Increase of authorized share capital of the Company from Rs. 20 Crores to Rs. 75 Crores and the consequent amendment of the Memorandum and Articles of Association of the Company. 2. To raise funds for the Company either from the International Markets through issue of Equity Shares/FCCBs/GDRs/ADRs and/or other securities (including debt instruments) to International investors and/or through domestic offerings to various investors either through an FPO/Preferential Issue/Rights Issue of Equity Shares or inter alia to the extent of Rs. 5000 million subject to the statutory approvals, SEBI (ICDR) Regulations, 2009, etc., as are applicable in this regard. 
18-Jun-08
Transgene Biotek Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on June 18, 2008, for obtaining the approval of the Members of the Company for allotment of 15,00,000 Equity Shares of Rs 10/- each at a price of Rs 80/- per Share or at the price to be determined as per the SEBI (Disclosure & Investor Protection) Guidelines, 2000, whichever is higher, to Dr. K Koteswara Rao, Promoter of the Company, against the interest free unsecured loans brought in by Dr. K Koteswara Rao and Family. 

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Apollo Hospitals 12,540.97 41.03 4.60 18.21 11.2 13.7 0.30
Fortis Health. 4,008.02 140.08 1.14 16.29 0.5 3.0 0.25
Opto Circuits 1,097.71 4.42 0.90 19.74 20.6 15.0 0.61
Poly Medicure 563.16 23.43 4.91 6.96 22.6 27.8 0.51
Indrapr.Medical 336.43 11.69 1.97 5.72 17.5 19.7 0.46
Kovai Medical 185.98 8.75 2.31 6.97 21.4 12.3 3.76
Looks Health 152.40 0.00 10.46 0.00 -28.7 -29.3 0.00
Secund. Health. 115.59 460.00 0.74 87.44 0.4 0.2 0.18
Fortis Malar 59.67 7.61 1.78 3.93 25.1 31.6 0.24
Emed.com Techno 46.71 0.00 11.25 0.00 0.0 0.0 0.00
Regency Hospital 43.52 12.37 1.55 8.39 9.8 11.1 1.41
Dr Agarwal's Eye 37.80 13.21 2.88 3.63 13.0 18.0 2.37
KMC Speciality 30.66 11.06 2.47 13.05 5.2 9.8 1.02
Noida Medicare 23.86 4.53 0.68 3.34 9.6 10.4 0.95
Span Diagnostics 18.02 19.19 0.62 6.65 -6.1 4.7 0.84

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

K Koteswara Rao , Chairman & Managing Director  

S S Marthi , Director  

P K Ghosh , Director  

P Narayana Murthy , Director  

Company Head Office / Quarters:
Plot No 68 69 & 70,
Anrich Indl Area IDA Bollaram,
Medak,
Andhra Pradesh-
Phone :
Fax :
E-mail :
Web : http://www.transgenebiotek.com
Registrars:
XL Softech Systems Ltd
Plot No 3 Sagar Soci
Road No 2
Banjara Hills
Hyderabad - 500034

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : India Finsec
Economic Events
list No economic event today
Results
list Bharat Forge | Oil India | Container Corpn.